Itepekimab (SAR440340)
EFC18418
Phase 3 small_molecule active
Quick answer
Itepekimab (SAR440340) for Chronic Rhinosinusitis With Nasal Polyps is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 4 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Chronic Rhinosinusitis With Nasal Polyps
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active